WDR5
Basic information
Region (hg38): 9:134135365-134159968
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
- not provided (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the WDR5 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 10 | |||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | ||||
non coding | 1 | |||||
Total | 1 | 0 | 10 | 0 | 0 |
Variants in WDR5
This is a list of pathogenic ClinVar variants found in the WDR5 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
9-134139882-C-T | not specified | Uncertain significance (Sep 29, 2023) | ||
9-134139896-A-C | not provided (-) | |||
9-134139910-G-T | not specified | Uncertain significance (Dec 02, 2022) | ||
9-134139942-C-G | not specified | Uncertain significance (Jul 14, 2021) | ||
9-134140716-A-G | not specified | Uncertain significance (Nov 11, 2024) | ||
9-134140728-C-T | not specified | Uncertain significance (Feb 15, 2024) | ||
9-134140796-T-C | WDR5-related neurodevelopmental delay | Likely pathogenic (Oct 07, 2024) | ||
9-134141539-G-A | not specified | Uncertain significance (Sep 16, 2021) | ||
9-134141552-A-T | not specified | Uncertain significance (Apr 25, 2023) | ||
9-134142039-G-GT | Neurodevelopmental disorder | Uncertain significance (Mar 12, 2024) | ||
9-134142369-T-G | Uncertain significance (Feb 08, 2024) | |||
9-134142670-C-T | Uncertain significance (Nov 01, 2023) | |||
9-134142686-G-T | Uncertain significance (Jul 02, 2024) | |||
9-134142703-C-T | Uncertain significance (Feb 22, 2022) | |||
9-134142715-C-T | Uncertain significance (Apr 11, 2024) | |||
9-134151984-C-T | Pathogenic (Feb 13, 2024) | |||
9-134152021-C-T | Pathogenic (Feb 01, 2024) | |||
9-134154486-T-G | not specified | Uncertain significance (Jul 27, 2021) | ||
9-134154511-G-A | Uncertain significance (Jan 12, 2024) | |||
9-134154514-A-G | Uncertain significance (Feb 08, 2024) | |||
9-134157962-A-G | Uncertain significance (Oct 13, 2022) | |||
9-134157967-A-G | Uncertain significance (May 22, 2023) | |||
9-134159934-TTC-T | Congenital heart disease | Uncertain significance (Jul 23, 2021) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
WDR5 | protein_coding | protein_coding | ENST00000358625 | 13 | 24607 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.00 | 0.000222 | 0 | 0 | 0 | 0 | 0.00 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 3.39 | 63 | 197 | 0.320 | 0.0000115 | 2180 |
Missense in Polyphen | 7 | 69.676 | 0.10047 | 796 | ||
Synonymous | 0.257 | 82 | 85.0 | 0.965 | 0.00000615 | 624 |
Loss of Function | 4.54 | 0 | 24.0 | 0.00 | 0.00000122 | 269 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.00 | 0.00 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Contributes to histone modification. May position the N- terminus of histone H3 for efficient trimethylation at 'Lys-4'. As part of the MLL1/MLL complex it is involved in methylation and dimethylation at 'Lys-4' of histone H3. H3 'Lys-4' methylation represents a specific tag for epigenetic transcriptional activation. As part of the NSL complex it may be involved in acetylation of nucleosomal histone H4 on several lysine residues. May regulate osteoblasts differentiation. {ECO:0000269|PubMed:16600877, ECO:0000269|PubMed:16829960, ECO:0000269|PubMed:19103755, ECO:0000269|PubMed:19556245, ECO:0000269|PubMed:20018852}.;
- Pathway
- Cushing,s syndrome - Homo sapiens (human);Gene expression (Transcription);Generic Transcription Pathway;Post-translational protein modification;Metabolism of proteins;PKMTs methylate histone lysines;RNA Polymerase II Transcription;RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function;RMTs methylate histone arginines;Chromatin modifying enzymes;HATs acetylate histones;Neddylation;Chromatin organization;Circadian rhythm pathway;Transcriptional regulation by RUNX1
(Consensus)
Recessive Scores
- pRec
- 0.178
Intolerance Scores
- loftool
- rvis_EVS
- -0.25
- rvis_percentile_EVS
- 35.42
Haploinsufficiency Scores
- pHI
- 0.368
- hipred
- Y
- hipred_score
- 0.841
- ghis
- 0.691
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- E
- essential_gene_gene_trap
- E
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.553
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Wdr5
- Phenotype
Gene ontology
- Biological process
- skeletal system development;neuron projection development;positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter;post-translational protein modification;histone H3 acetylation;histone H4-K5 acetylation;histone H4-K8 acetylation;histone H4-K16 acetylation;regulation of megakaryocyte differentiation;histone H3-K4 methylation
- Cellular component
- histone acetyltransferase complex;nucleus;nucleoplasm;Ada2/Gcn5/Ada3 transcription activator complex;histone methyltransferase complex;MLL3/4 complex;Set1C/COMPASS complex;MLL1 complex
- Molecular function
- protein binding;histone-lysine N-methyltransferase activity;methylated histone binding;histone binding;histone methyltransferase activity (H3-K4 specific);histone acetyltransferase activity (H4-K5 specific);histone acetyltransferase activity (H4-K8 specific);histone acetyltransferase activity (H4-K16 specific)